NuGene International Inc
Livento Group, Inc., through its subsidiaries, engages in the film and television production business in the United States. The company is also involved in the real estate finance and development; artificial intelligence; and machine learning technology businesses. It also provides Elisee, a software product that read market data and neurological network abilities to determine the path forward an… Read more
NuGene International Inc (NUGN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.001x
Based on the latest financial reports, NuGene International Inc (NUGN) has a cash flow conversion efficiency ratio of 0.001x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($52.50K) by net assets ($41.93 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
NuGene International Inc - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how NuGene International Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
NuGene International Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NuGene International Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Colibri Resource Corporation
PINK:CRUCF
|
-0.004x |
|
Fbec Worldwide
PINK:FBEC
|
0.002x |
|
Premier Biomedical Inc
PINK:BIEI
|
0.017x |
|
Cartica Acquisition Corp Warrant
NASDAQ:CITEW
|
-0.008x |
|
Cyon Exploration Ltd
PINK:CYNXF
|
0.066x |
|
PureWave Hydrogen Corp.
V:PWH
|
0.000x |
|
Compuage Infocom Limited
NSE:COMPINFO
|
0.009x |
|
Golden Star Acquisition Corporation Rights
NASDAQ:GODNR
|
N/A |
Annual Cash Flow Conversion Efficiency for NuGene International Inc (2013–2024)
The table below shows the annual cash flow conversion efficiency of NuGene International Inc from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $43.41 Million | $-155.90K | -0.004x | +64.33% |
| 2023-12-31 | $43.02 Million | $-433.14K | -0.010x | -138.70% |
| 2022-12-31 | $20.07 Million | $522.06K | 0.026x | -29.84% |
| 2021-12-31 | $20.19 Million | $748.61K | 0.037x | -89.38% |
| 2016-12-31 | $-5.74 Million | $-2.00 Million | 0.349x | -94.50% |
| 2015-12-31 | $-383.37K | $-2.43 Million | 6.351x | +3628.61% |
| 2014-12-31 | $1.37 Million | $-246.17K | -0.180x | -461.45% |
| 2013-12-31 | $20.30K | $1.01K | 0.050x | -- |